Skip to main content
Top
Published in: BMC Urology 1/2019

Open Access 01-12-2019 | Public Health | Research article

Testicular Cancer mortality in Brazil: trends and predictions until 2030

Authors: Samara Carollyne Mafra Soares, Katarina Márcia Rodrigues dos Santos, Fabia Cheyenne Gomes de Morais Fernandes, Isabelle Ribeiro Barbosa, Dyego Leandro Bezerra de Souza

Published in: BMC Urology | Issue 1/2019

Login to get access

Abstract

Background

Despite the fact that testicular cancer presents good prognosis, wide variations in mortality rates have been reported internationally. In Brazil, mortality trends and estimates have not been fully assessed. The objective of the study presented herein is to analyze the mortality trends for testicular cancer in Brazil in the period 2001–2015 and calculate mortality predictions for the period 2016–2030.

Methods

This is a population-based ecological study that utilized information of the Mortality Information System, on testicular cancer-related deaths in Brazil. Mortality trends were analyzed by Joinpoint regression, and Nordpred was utilized for the calculation of predictions.

Results

The mortality rate for men, standardized to the world population, varied between 0.36/100,000 for the year 2001, to 0.41/100,000 for the year 2015. There was an increasing trend for Brazil (APC = 1.3% CI95% 0.6; 2.0) and the Southeast region (APC = 1.5% CI95%0.2; 2.7). When analyzing Brazilian data for the period 2016–2030, predictions indicate 2888 deaths due to testicular cancer, which corresponds to a 26.6% change when compared to the 2011–2015 period. This change is mostly explained by an increase in the risk of death (14.2%) when compared with modifications in the demographic structure (12.4%).

Conclusions

Testicular cancer mortality in Brazil presents increasing trends, and until 2030 these rates continue to increase.
Literature
1.
go back to reference Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2018. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2018.
3.
go back to reference Smith ZL, Werntz RP, Eggener SE. Testicular Cancer: Epidemiology, Diagnosis, and Management Med Clin North Am. 2018;102:251–64.PubMed Smith ZL, Werntz RP, Eggener SE. Testicular Cancer: Epidemiology, Diagnosis, and Management Med Clin North Am. 2018;102:251–64.PubMed
4.
go back to reference Stewart BW, Wild CP. World cancer report 2014. France: Lyon; 2014. Stewart BW, Wild CP. World cancer report 2014. France: Lyon; 2014.
5.
go back to reference Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol. 2011;60:304–19.CrossRef Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol. 2011;60:304–19.CrossRef
6.
go back to reference Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. Guidelines on testicular Cancer: 2015 update. Eur Urol. 2015;68:1054–68.CrossRef Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. Guidelines on testicular Cancer: 2015 update. Eur Urol. 2015;68:1054–68.CrossRef
8.
go back to reference Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83:171–7.PubMedPubMedCentral Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83:171–7.PubMedPubMedCentral
11.
go back to reference Doll R, Payne P, Waterhouse J. Cancer incidence in five continents. v. 1. Geneva, Berlim: UICC: Springer; 1966. Doll R, Payne P, Waterhouse J. Cancer incidence in five continents. v. 1. Geneva, Berlim: UICC: Springer; 1966.
13.
go back to reference Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51.CrossRef Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–51.CrossRef
14.
go back to reference Møller B, Fekjær H, Hakulinen T, Sigvaldason H, Storm HH, Talbäck M, et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003;22:2751–66.CrossRef Møller B, Fekjær H, Hakulinen T, Sigvaldason H, Storm HH, Talbäck M, et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003;22:2751–66.CrossRef
15.
go back to reference Verhoeven RHA, Gondos A, Janssen-heijnen MLG, Saum KU, Brewster DH, Holleczek B, et al. Testicular cancer in Europe and the USA: survival still rising among older patients. Ann Oncol. 2013;24:508–13.CrossRef Verhoeven RHA, Gondos A, Janssen-heijnen MLG, Saum KU, Brewster DH, Holleczek B, et al. Testicular cancer in Europe and the USA: survival still rising among older patients. Ann Oncol. 2013;24:508–13.CrossRef
16.
go back to reference Le Cornet C, Lortet-Tieulent J, Forman D, Béranger R, Flechon A, Fervers B, et al. Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer. 2014;50:831–9.CrossRef Le Cornet C, Lortet-Tieulent J, Forman D, Béranger R, Flechon A, Fervers B, et al. Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data. Eur J Cancer. 2014;50:831–9.CrossRef
17.
go back to reference Park JS, Kim J, Elghiaty A, Ham WS. Recent global trends in testicular cancer incidence and mortality. Medicine (Baltimore). 2018;97:e12390.CrossRef Park JS, Kim J, Elghiaty A, Ham WS. Recent global trends in testicular cancer incidence and mortality. Medicine (Baltimore). 2018;97:e12390.CrossRef
18.
go back to reference Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. The Globocan Cancer observatory. Global Cancer observatory: Cancer today. Lyon, France:International Agency for Research on. Cancer. 2018; https://gco.iarc.fr/today. Accessed 20 Mar 2019. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. The Globocan Cancer observatory. Global Cancer observatory: Cancer today. Lyon, France:International Agency for Research on. Cancer. 2018; https://​gco.​iarc.​fr/​today. Accessed 20 Mar 2019.
19.
go back to reference Barbosa IR, Costa I do CC, Pérez MB, Souza DLB de. SOCIOECONOMIC INEQUALITY AND CANCER MORTALITY : AN ECOLOGICAL STUDY IN BRAZIL Desigualdades socioeconômicas e mortalidade por câncer : um estudo ecológico no Brasil Desigualdades socioeconómicas y mortalidad por cáncer : un estudio ecológico en Brasil. 2016;29:350–356. Barbosa IR, Costa I do CC, Pérez MB, Souza DLB de. SOCIOECONOMIC INEQUALITY AND CANCER MORTALITY : AN ECOLOGICAL STUDY IN BRAZIL Desigualdades socioeconômicas e mortalidade por câncer : um estudo ecológico no Brasil Desigualdades socioeconómicas y mortalidad por cáncer : un estudio ecológico en Brasil. 2016;29:350–356.
20.
go back to reference Bosetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F. Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol. 2011;60:1–15.CrossRef Bosetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F. Trends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol. 2011;60:1–15.CrossRef
21.
go back to reference Souza DLB, Jerez-Roig J, Cabral FJ, De Lima JRF, Rutalira MK, Costa JAG. Colorectal cancer mortality in Brazil: predictions until the year 2025 and cancer control implications. Dis Colon Rectum. 2014;57:1082–9.CrossRef Souza DLB, Jerez-Roig J, Cabral FJ, De Lima JRF, Rutalira MK, Costa JAG. Colorectal cancer mortality in Brazil: predictions until the year 2025 and cancer control implications. Dis Colon Rectum. 2014;57:1082–9.CrossRef
22.
go back to reference Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, Louis JS, et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013;14:391–436.CrossRef Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, Louis JS, et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013;14:391–436.CrossRef
23.
go back to reference Barbosa IR, Costa I do CC, Bernal MM, de SDLB. PRINCIPAIS CAUSAS DE ÓBITOS POR CÂNCER NO BRASIL , trends in mortality rates of the ten leading causes death cancer in Brazil , 1996-2012. Rev Ciência Plur. 2016;2:3–16. Barbosa IR, Costa I do CC, Bernal MM, de SDLB. PRINCIPAIS CAUSAS DE ÓBITOS POR CÂNCER NO BRASIL , trends in mortality rates of the ten leading causes death cancer in Brazil , 1996-2012. Rev Ciência Plur. 2016;2:3–16.
24.
go back to reference Antunes JLF, Toporcov TN, Biazevic MGH, Boing AF, Bastos JL. Gender and racial inequalities in trends of oral cancer mortality in Sao Paulo, Brazil. Rev Saude Publica. 2013;47:470–8.CrossRef Antunes JLF, Toporcov TN, Biazevic MGH, Boing AF, Bastos JL. Gender and racial inequalities in trends of oral cancer mortality in Sao Paulo, Brazil. Rev Saude Publica. 2013;47:470–8.CrossRef
28.
go back to reference Sharpe KH, McMahon AD, Raab GM, Brewster DH, Conway DI. Association between socioeconomic factors and cancer risk: a population cohort study in Scotland (1991-2006). PLoS One. 2014;9.CrossRef Sharpe KH, McMahon AD, Raab GM, Brewster DH, Conway DI. Association between socioeconomic factors and cancer risk: a population cohort study in Scotland (1991-2006). PLoS One. 2014;9.CrossRef
29.
go back to reference Stevenson SM, Lowrance WT. Epidemiology and diagnosis of testis Cancer. Urol Clin North Am. 2015;42:269–75.CrossRef Stevenson SM, Lowrance WT. Epidemiology and diagnosis of testis Cancer. Urol Clin North Am. 2015;42:269–75.CrossRef
30.
go back to reference Ondrus D, Ondrusova M, Dusek L. Recent patterns in testicular cancer incidence, mortality and survival in the Slovak Republic with reference to international comparisons. Cancer Investig. 2012;30:545–51.CrossRef Ondrus D, Ondrusova M, Dusek L. Recent patterns in testicular cancer incidence, mortality and survival in the Slovak Republic with reference to international comparisons. Cancer Investig. 2012;30:545–51.CrossRef
31.
go back to reference Bernal M, Romero FJ, Souza DLB, Gómez-Bernal FJ, Gómez-Bernal GJ. Estimation of the projections of incidence rates, prevalence and mortality due to prostate cancer in Aragon (Spain). Actas Urol españolas. 2011;35:470–4. Bernal M, Romero FJ, Souza DLB, Gómez-Bernal FJ, Gómez-Bernal GJ. Estimation of the projections of incidence rates, prevalence and mortality due to prostate cancer in Aragon (Spain). Actas Urol españolas. 2011;35:470–4.
Metadata
Title
Testicular Cancer mortality in Brazil: trends and predictions until 2030
Authors
Samara Carollyne Mafra Soares
Katarina Márcia Rodrigues dos Santos
Fabia Cheyenne Gomes de Morais Fernandes
Isabelle Ribeiro Barbosa
Dyego Leandro Bezerra de Souza
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Public Health
Published in
BMC Urology / Issue 1/2019
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-019-0487-z

Other articles of this Issue 1/2019

BMC Urology 1/2019 Go to the issue